WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005030212) 4-AMINOQUINOLINE-3-CARBOXAMIDE DERIVATIVES AS PDE4 INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/030212    International Application No.:    PCT/EP2004/010844
Publication Date: 07.04.2005 International Filing Date: 23.09.2004
IPC:
A61K 31/4706 (2006.01), A61K 31/4709 (2006.01), A61P 11/00 (2006.01), A61P 29/00 (2006.01), C07D 215/54 (2006.01), C07D 401/12 (2006.01), C07D 401/14 (2006.01), C07D 405/12 (2006.01), C07D 405/14 (2006.01)
Applicants: GLAXO GROUP LIMITED [GB/GB]; Glaxo Wellcome House, Berkeley Avenue, Greenford Middlesex UB6 0NN (GB) (For All Designated States Except US).
EDLIN, Christopher, D [GB/GB]; (GB) (For US Only).
ELDRED, Colin, David [GB/GB]; (GB) (For US Only).
KEELING, Steven, Philip [GB/GB]; (GB) (For US Only).
LUNNISS, Christopher, James [GB/GB]; (GB) (For US Only).
REDFERN, Tracy, Jane [GB/GB]; (GB) (For US Only).
REDGRAVE, Alison, Judith [GB/GB]; (GB) (For US Only).
WOODROW, Michael [GB/GB]; (GB) (For US Only)
Inventors: EDLIN, Christopher, D; (GB).
ELDRED, Colin, David; (GB).
KEELING, Steven, Philip; (GB).
LUNNISS, Christopher, James; (GB).
REDFERN, Tracy, Jane; (GB).
REDGRAVE, Alison, Judith; (GB).
WOODROW, Michael; (GB)
Agent: GIDDINGS, Peter, John; GlaxoSmithKline, 980 Great West Road, Brentford Middlesex TW8 9GS (GB)
Priority Data:
0322722.0 27.09.2003 GB
Title (EN) 4-AMINOQUINOLINE-3-CARBOXAMIDE DERIVATIVES AS PDE4 INHIBITORS
(FR) DERIVES DE 4-AMINOQUINOLINE-3-CARBOXAMIDE UTILISES COMME INHIBITEURS DE PDE4
Abstract: front page image
(EN)Compounds of formula (I) or pharmaceutically acceptable salts thereof: (I) are inhibitors of phosphodiesterase type IV (PDE4) and are of use in the treatment of inflammatory and/or allergic diseases.
(FR)Cette invention se rapporte à des composés représentés par la formule (I) ou à des sels pharmaceutiquement acceptables de ces composés, lesquels constituent des inhibiteurs de la phosphodiestérase de type IV (PDE4) et sont utiles dans le traitement des maladies inflammatoires et/ou allergiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)